The Dime

Before CBD was discussed by a President in the Oval Office, it was a medical necessity.The Charlotte Figi story is well documented — and powerful.Not because it was emotional, but because it forced a serious medical conversation.Stories like Charlotte’s change how physicians, regulators, and institutions think about where cannabinoid therapy belongs — not as a last resort, but as a legitimate option.Charlotte’s Web was built around that reality. By recognizing that cannabis does have medicinal properties — and that patients should have access to a plant-based option when it can materially improve quality of life — the company focused on trust, standards, and medical credibility first.This week, we sit down with Bill Morachnick to break down:Why CBD earned acceptance through medical trust, not consumer marketingHow physician comfort, reimbursement pathways, and standards changed the conversationCBD in the Oval Office — and what that signals for the future of cannabis Chapters00:00 Introduction to Charlotte's Web and Bill Morachnick03:00 The Inspiring Story of Charlotte Figi05:51 The Executive Order and Its Implications08:59 The Role of Education in CBD Acceptance12:12 Challenges and Misconceptions in the Cannabis Industry15:03 The Future of CBD and Medical Recommendations18:06 The Impact of Federal Reimbursement on CBD21:08 Defloria and the Future of Cannabis Research24:01 Navigating Regulatory Changes and Industry Challenges27:03 The Importance of Quality and Consistency in CBD Products30:02 The Potential for Pharmaceutical Collaborations33:04 Looking Ahead: The Future of CBD and Cannabis36:13 Final Thoughts and Audience EngagementSummaryIn this episode, Bryan Fields interviews Bill Morachnick, CEO of Charlotte's Web, discussing the company's inspiring origins, the recent executive order regarding CBD, and the future of cannabis as a medicinal product. Bill shares the powerful story of Charlotte Figi, whose life was transformed by CBD, and emphasizes the importance of education in changing perceptions about cannabis. The conversation also touches on the challenges faced by the industry, the potential for pharmaceutical collaborations, and the impact of federal reimbursement on CBD products.Guest Links:https://www.trycharlottesweb.com/https://www.charlottesweb.com/https://www.youtube.com/charlotteswebcbdhttps://www.instagram.com/charlotteswebcbd/https://www.linkedin.com/in/bill-morachnick-01318a6/https://www.linkedin.com/company/charlottesweb/Our Links:Bryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterExtraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.The Dime is a top 5% most shared  global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.🎥 YouTube:  The Dime📸 Instagram:  The Dimehttps://www.newton-insights.com/  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Everyone wants their product and brand to be known for consistency .Almost no one is willing to do the difficult work that makes consistency possible.This week we sit down with Ryan Crandall, Chief Commercial Officer at MariMed, to break down:Why most cannabis brands fail at scale — and how process control, not an artisanal mindset, determines who lastsHow MariMed engineers consistency across states by centralizing inputs & testing aggressively,What it actually takes to make effects-based products consistent and repeatable Chapters00:00 Introduction to the Cannabis Industry and Edibles03:05 The Evolution of Edibles: From Early Days to Now06:01 Ensuring Consistency Across State Lines09:09 Quality Control and Testing in Edibles12:01 Consumer Education and Brand Trust15:13 MariMed Brand Portfolio and Market Strategy18:06 Role of R&D in Product Development21:00 Future Trends and Innovations in Edibles24:03 Building Relationships with Budtenders and Consumers27:58 Exploring Cannabinoids: THCV and CBG Effects30:06 Understanding Edible Experiences and Consumer Expectations32:00 Responsible Product Development in the Cannabis Industry33:52 Brand Strategy and Market Penetration in New States35:51 Innovative Products: Vibations and Consumer Convenience38:04 Navigating the Hemp Market and Brand Expansion39:52 Consumer Behavior: Beverages vs. Edibles in Cannabis44:02 The Importance of Team and Company CultureGuest Links:https://www.marimedinc.com/https://www.linkedin.com/company/marimed-inc/about/https://www.linkedin.com/in/ryan-crandall-43133b12/https://x.com/MariMed_IncSummaryIn this episode, Bryan Fields interviews Ryan Crandall, Chief Commercial Officer at MariMed, discussing the evolution of the cannabis industry, particularly focusing on edibles. They explore the importance of consistency in product quality across different states, the role of research and development in product innovation, and the significance of branding and consumer trust. Ryan shares insights into MariMeds diverse product portfolio and their approach to quality control and testing procedures. The conversation also touches on the future of hemp and cannabinoids, as well as the beverage market's impact on consumer behavior.Our Links:Bryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterExtraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.The Dime is a top 5% most shared  global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.🎥 YouTube:  The Dime📸 Instagram:  The Dimehttps://www.newton-insights.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Schedule III isn’t the finish line.It’s the starting gun.The EO said a lot — but most operators aren’t ready for what it actually means.This week we sit down with Zach Edge and Dr. Matthew Moore to break down:Why Schedule III is guidance, not rules — and why the real impact comes during rulemakingWhat GMP, CFR, and pharmaceutical-grade manufacturing will actually require from operatorsWhich parts of the supply chain face the biggest disruption as cannabis moves forwardChapters00:00 Historic Changes in Cannabis Scheduling03:13 The Impact of Hemp in the New Landscape06:07 Strategic Shifts for Cannabis Operators08:59 Navigating Regulatory Changes11:58 The Role of Pharmacies in the New Market15:04 Global Trade and Competition in Cannabis17:53 Research Opportunities and Challenges21:02 Veterans and the Future of CBD24:02 The Supply Chain Dynamics26:47 The Future of Hemp and CBD Products29:56 Final Thoughts on the Cannabis Industry Summary:In this episode, Bryan Fields discusses the recent changes in cannabis scheduling with experts Zach Edge and Matthew Moore. They explore the implications of the new executive order, particularly regarding hemp and its potential impact on the industry. The conversation delves into the strategic shifts that cannabis operators need to consider, the role of compounding pharmacies, and the opportunities for research that arise from the new regulations. They also discuss the challenges in the supply chain and the potential market dynamics as the industry evolves. Guest Links:https://www.linkedin.com/company/the-rho-advisory/https://www.linkedin.com/in/zach-edge/https://www.linkedin.com/in/mmoore09/Our Links:Bryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterExtraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.The Dime is a top 5% most shared  global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.🎥 YouTube:  The Dime📸 Instagram:  The Dimehttps://www.newton-insights.com/  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

SNDL is much bigger than most people realize — with global distribution, massive extraction capacity, and a diversified retail and manufacturing engine that touches nearly every part of the cannabis supply chain.This week we sit down with Tyler Robson, President of SNDL, to break down:• How SNDL became a global manufacturing and retail powerhouse• Why extraction and derivatives are their true competitive edge• How they operate across countries with completely different rules and product formatsChapters00:00 Introduction to Sundial and Tyler Robson02:08 The Complexity of Extraction and Manufacturing04:38 Merging Sundial and Valens: Challenges and Strategies06:11 Sundial's Operations and Global Reach07:39 Firefighting and Problem Solving in Leadership09:52 Data-Driven Decision Making12:44 Navigating Different Regulatory Environments13:55 Core Competencies and Operational Efficiencies15:46 Staying Focused in a Distracted Industry16:18 Sundial's Market Position and Brand Partnerships17:10 Strategic Focus on Texas and Florida19:09 Resource Planning and Flexibility20:42 Continuous Improvement in Manufacturing22:34 Synergies Between Liquor and Cannabis24:48 Future of Cannabis and Liquor Co-Mingling26:30 Emerging International Markets28:23 Potential Partnerships and Collaborations30:08 The Size of the Global Cannabis Opportunity31:31 Strategic Partnerships in the US32:03 Conclusion and Key TakeawaysSummaryIn this episode, Tyler Robson, president of Sundial, shares insights into his journey in the cannabis industry, the complexities of extraction and manufacturing, and the challenges of merging companies. He discusses Sundial's global operations, the importance of data-driven decision making, and the need for focus in a distracted industry. Tyler also highlights the potential for growth in emerging markets and the synergies between the cannabis and liquor industries, while emphasizing the significance of strategic partnerships.Guest Links:https://sndl.com/homepage/default.aspxhttps://www.linkedin.com/in/tyler-robson-a77ba4155/https://www.linkedin.com/company/sndlinc/[email protected] Links:Bryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterExtraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.The Dime is a top 5% most shared  global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.🎥 YouTube:  The Dime📸 Instagram:  The Dimehttps://www.newton-insights.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Most operators think debt is dangerous. But what if the real problem is how we think about it?The opposite is true: when used correctly, debt is the single biggest growth lever in cannabis. Every major industry scales on borrowed capital — cannabis is the only one still trying to do it alone.This week we sit down with Adam Stettner to discuss:• Why debt — used properly — compounds growth• The difference between smart leverage and over-leverage• How operators can fix cash-flow bottlenecks and scale predictablyChapters00:00 Introduction to Adam Stettner and FundCanna.03:05 Adam's Journey into the Cannabis Industry06:12 Understanding Underwriting in Cannabis Financing09:05 The Importance of Client-Centric Financing11:56 Navigating Complex Variables in Cannabis Lending14:57 Building Infrastructure for Cannabis Financing17:48 Segmenting the Cannabis Industry for Better Insights20:55 The Unique Challenges of Cannabis Lending24:12 The Role of Transparency in Client Relationships28:23 Building Partnerships for Success29:29 Funding Options for Operational Efficiency32:29 Understanding Technology and Business Operations37:54 Navigating Debt and Financial Strategies42:10 Using Debt to Accelerate Growth52:46 Exploring Funding OpportunitiesSummaryIn this episode, Bryan Fields and Kellen Finney welcome Adam Stettner, CEO of FundCanna, to discuss the complexities of cannabis financing. Adam shares his journey from the apparel industry to cannabis, emphasizing the importance of understanding the unique challenges of underwriting in this space. He highlights the need for a client-centric approach in lending, the significance of transparency, and the innovative strategies FunCounter employs to navigate the cannabis market. Adam also discusses the importance of knowledge sharing and the metrics that indicate success in cannabis financing. In this conversation, Adam Stettner discusses the importance of building partnerships in the cannabis industry, focusing on how funding can enhance operational efficiency and support business growth. He emphasizes the need for flexible financial solutions that allow businesses to thrive without being constrained by debt. Stettner also highlights the significance of understanding technology and its impact on business operations, advocating for a metrics-based approach to financial decisions. The discussion concludes with insights on leveraging debt as a tool for growth and the importance of fostering relationships in the industry.  Guest Links:https://fundcanna.comhttps://fundcanna.com/about/adam-stettner/https://www.linkedin.com/in/adamstettnerhttps://www.linkedin.com/company/fundcanna/About Adam Stettner:Adam has 30 years of business, strategy and leadership experience in both Private and Public Companies. In 2021, Adam believed the timing and opportunity was right for him to bring his passion for business, innovative financing and entrepreneurial spirit to the Cannabis sector by creating funding products for all areas of this early stage, growth industry by founding FundCanna. FundCanna provides short term funding to all areas of the sector; cultivators, manufacturers, vendors, suppliers, distributors and retailers. In just its first year, FundCanna has underwritten roughly 3000 files and funded over 500 unique files bringing much needed liquidity and financing solutions to the legal Cannabis industry.Our Links:Bryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterExtraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.The Dime is a top 5% most shared  global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.🎥 YouTube:  The Dime📸 Instagram:  The Dimehttps://www.newton-insights.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.